UK guidelines promise boost in genetics cascade screening (and early treatments)
This article was originally published in Scrip
Genetic testing guidelines published yesterday in the UK may significantly increase the use of genetic 'cascade' screening for familial predispositions. The guidelines address some of the obstacles to the extended use of genetic screening within families and conclude that, with appropriate safeguards, more genetic cascading will provide an overall cost-benefit to the UK’s health provider, the National Health Service.
You may also be interested in...
Trade group also compiled website with information and resources to help members "stay up to date and take any necessary steps to mitigate the risks associated with COVID-19." Its members also got a chance to describe potential supply chain disruptions in survey for USDA.
Companies are racing to co-develop coronavirus treatments before finalizing deal teams. These team-ups raise questions about what happens after the pandemic subsides.
Plaintiffs against the prestige, “clinical” skin-care company are targeting anti-aging claims on its Rose Stem Cell Bio-Repair line and statements about hyaluronic acid’s ultra-moisturizing capabilities, used to market its Water Drench range. PTR faces false advertising class actions in California and New York federal courts, and the former case appears to be headed for trial.